BioCentury
ARTICLE | Company News

Medivir, MedCap AB deal

July 15, 2013 7:00 AM UTC

Medivir sold its wholly owned subsidiary Cross Pharma AB to MedCap's Unimedic AB subsidiary for SEK125 million ($18.7 million) on a cash and debt free basis. The companies could not be reached for det...